Fayez Sarofim & CO Abbott Laboratories Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Fayez Sarofim & CO holds 4,189,770 shares of ABT stock, worth $524 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

4,189,770

Previous 4,130,719 1.43%

Holding current value

$524 Million

Previous $429 Million 11.29%

% of portfolio

1.23%

Previous 1.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $5.91 Million - $6.98 Million	59,051 Added 1.43%	4,189,770 $478 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $10.2 Million - $11.4 Million	101,432 Added 2.52%	4,130,719 $429 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $319,907 - $353,324	-2,921 Reduced 0.07%	4,029,287 $458 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $24.3 Million - $29.7 Million	-269,128 Reduced 6.26%	4,032,208 $444 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $35.4 Million - $42.4 Million	370,199 Added 9.42%	4,301,336 $417 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $14.9 Million - $16.6 Million	-148,160 Reduced 3.63%	3,931,137 $429 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $18.4 Million - $21.6 Million	-189,866 Reduced 4.45%	4,079,297 $413 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $25.9 Million - $30.4 Million	-272,636 Reduced 6.0%	4,269,163 $469 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.6 Million - $1.85 Million	-16,520 Reduced 0.36%	4,541,799 $439 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $2.08 Million - $2.51 Million	-20,337 Reduced 0.44%	4,558,319 $495 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $18 Million - $21.9 Million	-157,866 Reduced 3.33%	4,578,656 $542 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $3.11 Million - $3.81 Million	-26,942 Reduced 0.57%	4,736,522 $667 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $25 Million - $27.7 Million	214,418 Added 4.71%	4,763,464 $563 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $1.54 Million - $1.82 Million	14,591 Added 0.32%	4,549,046 $527 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $781,906 - $921,204	7,184 Added 0.16%	4,534,455 $543 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $3.76 Million - $4.1 Million	35,834 Added 0.8%	4,527,271 $496 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $13.2 Million - $16 Million	144,195 Added 3.32%	4,491,437 $489 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $51 Million - $65.2 Million	665,577 Added 18.08%	4,347,242 $397 Million
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $543,016 - $794,037	8,644 Added 0.24%	3,681,665 $291 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $7.06 Million - $7.86 Million	-89,957 Reduced 2.39%	3,673,021 $319 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $3.58 Million - $3.88 Million	43,772 Added 1.18%	3,762,978 $315 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $6.32 Million - $7.37 Million	-86,744 Reduced 2.28%	3,719,206 $313 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $726,963 - $878,898	10,978 Added 0.29%	3,805,950 $304 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $4.77 Million - $5.41 Million	-72,834 Reduced 1.88%	3,794,972 $274 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $3.29 Million - $3.98 Million	-54,185 Reduced 1.38%	3,867,806 $284 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $5.01 Million - $5.53 Million	-86,997 Reduced 2.17%	3,921,991 $239 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $2.68 Million - $3.03 Million	-47,632 Reduced 1.17%	4,008,988 $240 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $13.9 Million - $14.9 Million	-258,895 Reduced 6.0%	4,056,620 $232 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $207 Million - $231 Million	4,315,515	4,315,515 $230 Million

Others Institutions Holding ABT

# of Institutions

3,204

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $219B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account